[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey Esq.", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 56, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP and Chief Corporate Affairs & Advocacy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Henrietta  Ukwu FACP FRAPS, M.D.", "age": 57, "title": "Executive VP & Chief Regulatory Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 6, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.43, "open": 9.49, "dayLow": 9.2722, "dayHigh": 9.89, "regularMarketPreviousClose": 9.43, "regularMarketOpen": 9.49, "regularMarketDayLow": 9.2722, "regularMarketDayHigh": 9.89, "payoutRatio": 0.0, "beta": 2.5, "trailingPE": 4.3153152, "forwardPE": -59.875, "volume": 7168555, "regularMarketVolume": 7168555, "averageVolume": 7843404, "averageVolume10days": 9863770, "averageDailyVolume10Day": 9863770, "bid": 9.53, "ask": 9.77, "bidSize": 10, "askSize": 5, "marketCap": 1556002688, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 15.22, "priceToSalesTrailing12Months": 1.4424555, "fiftyDayAverage": 7.1758, "twoHundredDayAverage": 7.71165, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1172185344, "profitMargins": 0.39196998, "floatShares": 136723292, "sharesOutstanding": 162422000, "sharesShort": 42311894, "sharesShortPriorMonth": 46558353, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.26049998, "heldPercentInsiders": 0.08756, "heldPercentInstitutions": 0.58927, "shortRatio": 8.53, "shortPercentOfFloat": 0.2615, "impliedSharesOutstanding": 162422000, "bookValue": 0.232, "priceToBook": 41.293106, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": -0.344, "netIncomeToCommon": 422824000, "trailingEps": 2.22, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 1.087, "enterpriseToEbitda": 2.876, "52WeekChange": -0.31079137, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 9.58, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.14286, "targetMedianPrice": 9.0, "recommendationMean": 2.57143, "recommendationKey": "hold", "numberOfAnalystOpinions": 7, "totalCash": 612304000, "totalCashPerShare": 3.77, "ebitda": 407505984, "totalDebt": 228490000, "quickRatio": 2.155, "currentRatio": 2.363, "totalRevenue": 1078717952, "debtToEquity": 607.282, "revenuePerShare": 6.705, "returnOnAssets": 0.14515, "grossProfits": 616860992, "freeCashflow": -627235008, "operatingCashflow": -630940992, "earningsGrowth": -0.381, "revenueGrowth": -0.424, "grossMargins": 0.57185, "ebitdaMargins": 0.37777, "operatingMargins": 0.44169, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.6 - Hold", "cryptoTradeable": false, "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "corporateActions": [], "postMarketTime": 1755302371, "regularMarketTime": 1755288001, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.59066, "regularMarketPrice": 9.58, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "postMarketChangePercent": 0.52192265, "postMarketPrice": 9.63, "postMarketChange": 0.05000019, "regularMarketChange": 0.15, "regularMarketDayRange": "9.2722 - 9.89", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 7843404, "fiftyTwoWeekLowChange": 4.5699997, "fiftyTwoWeekLowChangePercent": 0.91217554, "fiftyTwoWeekRange": "5.01 - 15.22", "fiftyTwoWeekHighChange": -5.6400003, "fiftyTwoWeekHighChangePercent": -0.37056506, "fiftyTwoWeekChangePercent": -31.079138, "dividendDate": 1557446400, "earningsTimestamp": 1754483400, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754483400, "earningsCallTimestampStart": 1754483400, "earningsCallTimestampEnd": 1754483400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.22, "epsForward": -0.16, "epsCurrentYear": 1.86686, "priceEpsCurrentYear": 5.1316113, "fiftyDayAverageChange": 2.4042, "fiftyDayAverageChangePercent": 0.3350428, "twoHundredDayAverageChange": 1.86835, "twoHundredDayAverageChangePercent": 0.2422763, "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]